Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized open-label trial of intravenous iron regimens after colorectal cancer surgery
2015-001005-13Phase 4Completed
- Sponsor
- Fundació Parc Taulí
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ferric carboxymaltose in postoperative anemia and iron deficiency anemia (IDA) (2 arms), sponsored by Fundació Parc Taulí. Primary endpoint: Change in hemoglobin levels from postoperative day 1 to day 30. Started Jun 2015; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
postoperative anemiairon deficiency anemia (IDA)
Beyond the preview
Go deeper on 2015-001005-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001005-13.